Loading data
AGMHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 30.56 m USD | 32.04 m USD | 68.76 m USD | 203.11 m USD | 36.71 m USD |
| Cost of revenue | 27.41 m USD | 25.19 m USD | 65.61 m USD | 160.84 m USD | 30.11 m USD |
| Gross profit | 3.16 m USD | 6.86 m USD | 3.15 m USD | 42.27 m USD | 6.6 m USD |
| Research and development expense | — | — | — | — | 36.32 k USD |
| Selling, general and administrative expense | — | — | 13.87 m USD | 30.4 m USD | 1.61 m USD |
| Operating profit | -4.68 m USD | 5.95 m USD | 15.82 m USD | 12.64 m USD | 4.95 m USD |
| Interest expense | — | — | 15.23 k USD | — | — |
| Profit before tax | 3.47 m USD | 5.74 m USD | 15.51 m USD | 12.19 m USD | 4.96 m USD |
| Income tax expense | 2.9 m USD | 2.33 m USD | 4.09 m USD | 3.44 m USD | 1.41 m USD |
| Net income (reported basis) | 561.63 k USD | 3.12 m USD | -7.44 m USD | 11.48 m USD | 3.55 m USD |
| Basic earnings per share | 0.32 USD/share | 6.44 USD/share | -15.33 USD/share | 0.47 USD/share | 0.17 USD/share |
| Diluted earnings per share | 0.32 USD/share | 6.44 USD/share | -15.33 USD/share | 0.47 USD/share | 0.17 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.